Table I.
Clinical characteristics of the study group
| Parameter | Study group (n = 51) |
|---|---|
| Age at disease onset [years] | 9.79 ±4.36 |
| Disease duration [years] | 4.98 ±3.90 |
| Gender, n (%): | |
| Male | 32 (62.75) |
| Female | 19 (37.25) |
| Body mass index [kg/m2] | 21.87 (13.87–30.42) |
| Area of residence, n (%): | |
| Rural | 22 (43.14) |
| Urban | 29 (56.86) |
| Education level of the primary caretaker, n (%): | |
| Vocational | 10 (19.61) |
| High school | 20 (39.22) |
| University level | 15 (29.41) |
| No data | 6 (11.76) |
| Employment of the primary caretaker, n (%): | |
| Yes | 33 (64.71) |
| No | 17 (33.33) |
| No data | 1 (1.96) |
| Family model, n (%): | |
| Traditional | 45 (88.24) |
| Mother + children | 4 (7.8) |
| Mother + partner | 1 (1.96) |
| No data | 1 (1.96) |
| Mode of education, n (%): | |
| Regular schooling | 44 (86.28) |
| Individualized education at school | 4 (7.84) |
| Individualized education at home | 3 (5.88) |
| eGFR | 107.25 (48.8–178.97) |
| Proteinuria, n (%) | 39 (76.49) |
| Hypertension, n (%) | 13 (25.5) |
| Past steroid treatment, n (%) | 36 (70.59) |
| Current steroid treatment, n (%) | 15 (29.41) |
| Current immunosuppressive treatment, n (%) | 10 (19.61) |